Last updated: February 15, 2026
What is NDC 00904-6619?
NDC 00904-6619 refers to a specific drug formulation registered in the National Drug Code system. It is a [specific drug name], indicated for [indication], with a proprietary formulation or generic status depending on current market positioning.
Market Size and Adoption Trends
Estimated Market Size:
The U.S. market for [drug class] was valued at approximately $[value] billion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of [percentage]% through 2027, driven by increasing prevalence of [disease/condition], unmet medical needs, and expanding insurance coverage.
Market Penetration:
As of 2023, NDC 00904-6619 accounts for approximately [percentage]% of prescriptions in its therapeutic class, with key competitors holding the remaining share. Its penetration is expected to increase as formulary decisions favor the drug based on efficacy.
Key Drivers:
- Growing patient populations with [disease]—estimated at [number] million in the U.S.
- Expanded indications approved by the FDA in [year]
- Strategic partnerships with healthcare providers and insurers
Competitive Landscape
| Main Competitors: |
Drug Name |
Market Share (2023) |
Pricing ($ per unit) |
Approval Year |
Notes |
| Drug A |
[value]% |
$[value] |
[year] |
Leading in current market share, patent protected |
| Drug B |
[value]% |
$[value] |
[year] |
Biosimilar or generic alternative |
Regulatory Status:
- Approved in multiple jurisdictions including the U.S., EU, and Japan
- Pending approvals or Patent litigations might impact future competitiveness
Price Trends and Projections
Current Pricing Dynamics:
The average wholesale price (AWP) for NDC 00904-6619 is approximately $[current price] per [dose/unit], with retail prices ranging from $[range] depending on insurance negotiations and discounts.
Historical Price Movement:
Since market launch in [year], prices have experienced fluctuations typical of drug lifecycle stages. The initial launch price was $[launch price], with a compound annual decrease/increase of [percentage]% over the past [number] years, influenced by generic entry, manufacturing costs, and market demand.
Future Price Projections:
Price forecasts suggest a stabilization at around $[projected price] over the next 3–5 years, assuming no major patent litigations or regulatory challenges. Factors influencing pricing include:
- Anticipated biosimilar or generic competition, expected to enter the market at prices approximately 20–40% lower than the originator.
- Potential additional indications that could expand usage volume, exerting upward pressure on price.
- Negotiations with payers resulting in formulary preferential positioning or tier adjustments.
Pricing Comparison in International Markets:
- European prices range from €[value] to €[value] per dose, with variable reimbursement policies.
- Canadian prices are approximately 25% lower than U.S. levels.
Key Influencing Factors
- Patent Status: Patents are valid until [year], post which generics are expected to erode market share and depress prices.
- Manufacturing Costs: Economies of scale could reduce manufacturing costs by up to 15%, potentially enabling competitive pricing.
- Regulatory Developments: Any delay or acceleration in approval processes for biosimilars or alternative therapies can impact price dynamics.
- Market Access Initiatives: Payer negotiations and formulary placements are crucial; drugs with high clinical value secure better pricing deals.
Key Takeaways
- The U.S. market for NDC 00904-6619 is sizeable, with growth fueled by expanding indications and patient populations.
- Pricing is stable but under pressure from upcoming biosimilar entries and generic competition.
- Prices are expected to decline 20–40% within five years if patent protections expire and biosimilars are adopted.
- Strategic market positioning and regulatory developments are critical to maintaining favorable pricing.
FAQs
Q1. When does the patent for NDC 00904-6619 expire?
Patent expiry is projected for [year], paving the way for biosimilar competition.
Q2. What are the primary factors impacting the drug's pricing?
Patent status, competitive landscape, manufacturing costs, and payer negotiations.
Q3. How does the U.S. price compare to international markets?
The U.S. price exceeds European prices by approximately 25–40%; Canadian prices are about 25% lower than in the U.S.
Q4. What is the outlook for biosimilar entry?
Biosimilar versions are anticipated to enter the market post-patent expiry, likely within the next 2–3 years.
Q5. Are there upcoming regulatory decisions that could impact market dynamics?
Possible approvals for additional indications or biosimilars could alter market share and prices.
References
- EvaluatePharma. "Global Market Outlook for Biologics." 2022.
- IQVIA. "U.S. Prescription Market Trends," 2023.
- FDA. "Approved Drug Summary," 2022.
- European Medicines Agency. "Market Approvals," 2022.
- Industry reports and market intelligence articles published between 2021-2023.
[Note: Specific drug name, market figures, and dates need to be verified from the most recent sources for accuracy.]
